TANTTI - Key Persons
Ph.D. in Biochemical Engineering; specialized in bioprocess development, with 15+ years of leadership experience in the wastewater treatment and biotechnology research sectors, including at Imperial College London and National Health Research Institutes, Taiwan.
Dr. Hu was the Senior VP of R&D and New Business Development at Unimicron Technology Corp. (TPE:3037) from 2010-2014. He was also previously the CEO for Chip Power Technology Corp. Dr. Hu earned his Ph.D. in Material Science and Engineering from the Massachusetts Institute of Technology(MIT).
Dr. Chen is currently Tantti's Chief Technology Officer (CTO).
Prior to Tantti, Dr. Chen was a Professor of Chemical and Materials Engineering at National Central University in Taiwan.
Dr. Chen earned his Ph.D. in Polymer Chemistry from the Tokyo Institute of Technology.
Dr. Lee is currently the Chairman of Tantti's Advisory Board.
Prior to Tantti, he was with the Institute for Information Industry and with Datatrans System Inc.
Dr. Lee earned his Ph.D. in Computer Science and Information Engineering from National Central University in Taiwan.
Dr. Lai has been the Professor of Chemical and Materials Engineering at Chung Yuan Christian University (CYCU) in Taiwan since 2006.
At CYCU, he is the founder of the R&D Center for Membrane Technology (2000).
He is also a National Endowed Chair Professor (2014).
Ph.D. in Bioengineering; specialized in biomaterials, with 25+ years of product R&D leadership experience in the medical device and biotechnology industries, including Boston Scientific Corp., Covidien (merged with Medtronic), and Sunmax Biotechnology.
Since 2003, Dr. Lin has been a Professor in the Department of Material Science and Engineering at National Chiao Tung University in Taiwan.
Dr. Lin earned his Ph.D. in Material Science and Engineering from the University of California, Los Angeles (UCLA)
Served in senior finance positions in several public and startup companies, including Ford Moto Taiwan, Boehringer Ingelheim Taiwan, Taiwan Biotech Co., Sagittarius Life Science Corp. (brought to IPO) and Concord Medical Co.
Joe Yang - CEO, President
For 20+ years has served in senior leadership roles at several biopharma startups and successfully brought a startup to IPO, Sagittarius Life Science Corp.
Job Titles:
- Director, Corp. Development / Corporate Finance Professional With 17 Years of Experience Advising on Mergers and Acquisitions, Divestitures, and Public and Private Capital Raising.
Corporate finance professional with 17+ years of experience advising on mergers and acquisitions, divestitures, and public and private capital raising.
Served in senior R&D and management positions at several public and startup companies, including Sagittarius Life Science Corp., Taiwan Biotech Co. Ltd. and King to Nin Jiom Medicine Manufactory Co. Ltd. Specializes in drug development, GMP and ISO.